A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR 1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma

Type of Cancer
Lymphoma

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR 1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.